Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pomerantz

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Nature Medicine|October 9, 2019
Genome-wide germline correlates of the epigenetic landscape of prostate cancerKathleen E Houlahan, Yu-Jia Shiah, Alexander Gusev, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Nature Medicine|December 4, 2023
Author Correction: Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
European Urology|April 18, 2019
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective AnalysisKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium StudyKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA|March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate CancerAmar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
Nature Genetics|July 22, 2020
Prostate cancer reactivates developmental epigenomic programs during metastatic progressionMark M Pomerantz, Xintao Qiu, Yanyun Zhu, et al.
Cancer Discovery|February 13, 2025
The Germline and Somatic Origins of Prostate Cancer HeterogeneityTakafumi N Yamaguchi, Kathleen E Houlahan, Helen Zhu, et al.
European Journal of Human Genetics : EJHG|June 25, 2019
Sex specific associations in genome wide association analysis of renal cell carcinomaRuhina S Laskar, David C Muller, Peng Li, et al.
European Urology|June 2, 2018
Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]Mitchell J Machiela, Jonathan N Hofmann, Robert Carreras-Torres, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Nature Medicine|October 9, 2019
Genome-wide germline correlates of the epigenetic landscape of prostate cancerKathleen E Houlahan, Yu-Jia Shiah, Alexander Gusev, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Nature Medicine|December 4, 2023
Author Correction: Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
European Urology|April 18, 2019
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective AnalysisKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium StudyKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
JAMA|March 7, 2018
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate CancerAmar U Kishan, Ryan R Cook, Jay P Ciezki, et al.
Nature Genetics|July 22, 2020
Prostate cancer reactivates developmental epigenomic programs during metastatic progressionMark M Pomerantz, Xintao Qiu, Yanyun Zhu, et al.
Cancer Discovery|February 13, 2025
The Germline and Somatic Origins of Prostate Cancer HeterogeneityTakafumi N Yamaguchi, Kathleen E Houlahan, Helen Zhu, et al.
European Journal of Human Genetics : EJHG|June 25, 2019
Sex specific associations in genome wide association analysis of renal cell carcinomaRuhina S Laskar, David C Muller, Peng Li, et al.
European Urology|June 2, 2018
Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]Mitchell J Machiela, Jonathan N Hofmann, Robert Carreras-Torres, et al.
Pageof 26